标题
A review of bevacizumab in the treatment of malignant pleural mesothelioma
作者
关键词
-
出版物
Future Oncology
Volume 13, Issue 28, Pages 2537-2546
出版商
Future Medicine Ltd
发表日期
2017-09-20
DOI
10.2217/fon-2017-0307
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Phase I Trial of Cediranib in Combination with Cisplatin and Pemetrexed in Chemonaive Patients with Unresectable Malignant Pleural Mesothelioma (SWOG S0905)
- (2017) Anne S. Tsao et al. Journal of Thoracic Oncology
- Patterns of care and survival among patients with malignant mesothelioma in the United States
- (2017) Lindsey Enewold et al. LUNG CANCER
- A Randomized Phase II Study Adding Axitinib to Pemetrexed-Cisplatin in Patients with Malignant Pleural Mesothelioma: A Single-Center Trial Combining Clinical and Translational Outcomes
- (2016) Wieneke A. Buikhuisen et al. Journal of Thoracic Oncology
- The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma
- (2016) David Rice et al. Journal of Thoracic Oncology
- The IASLC Mesothelioma Staging Project: Proposals for the M Descriptors and for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Mesothelioma
- (2016) Valerie W. Rusch et al. Journal of Thoracic Oncology
- The IASLC Mesothelioma Staging Project: Proposals for Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma
- (2016) Anna K. Nowak et al. Journal of Thoracic Oncology
- Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
- (2016) Gérard Zalcman et al. LANCET
- Increased risk of hemorrhage in metastatic colorectal cancer patients treated with bevacizumab
- (2016) Xiaoqiang Zhu et al. MEDICINE
- Survival patterns in lung and pleural cancer in Europe 1999–2007: Results from the EUROCARE-5 study
- (2015) Silvia Francisci et al. EUROPEAN JOURNAL OF CANCER
- Molecular Classification of Malignant Pleural Mesothelioma: Identification of a Poor Prognosis Subgroup Linked to the Epithelial-to-Mesenchymal Transition
- (2014) Aurélien de Reyniès et al. CLINICAL CANCER RESEARCH
- Phase II study of pemetrexed and carboplatin plus bevacizumab as first-line therapy in malignant pleural mesothelioma
- (2013) G L Ceresoli et al. BRITISH JOURNAL OF CANCER
- Bevacizumab and central nervous system (CNS) hemorrhage
- (2013) Nathalie Letarte et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase 2 Study of Sorafenib in Malignant Mesothelioma Previously Treated with Platinum-Containing Chemotherapy
- (2013) Sophie Papa et al. Journal of Thoracic Oncology
- Thalidomide versus active supportive care for maintenance in patients with malignant mesothelioma after first-line chemotherapy (NVALT 5): an open-label, multicentre, randomised phase 3 study
- (2013) Wieneke A Buikhuisen et al. LANCET ONCOLOGY
- Gastrointestinal perforation associated with bevacizumab use in metastatic colorectal cancer: Results from a large treatment observational cohort study
- (2012) Fairooz F. Kabbinavar et al. EUROPEAN JOURNAL OF CANCER
- Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma
- (2012) Hedy L. Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Robust Data: The Essential Foundation of a Revised Staging System for Pleural Mesothelioma
- (2012) Hedy Lee Kindler Journal of Thoracic Oncology
- A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma
- (2012) Jonathan E. Dowell et al. LUNG CANCER
- Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium
- (2012) Nicholas P. Campbell et al. LUNG CANCER
- Wound healing and catheter thrombosis after implantable venous access device placement in 266 breast cancers treated with bevacizumab therapy
- (2011) Irène Kriegel et al. ANTI-CANCER DRUGS
- Risk of high-grade bleeding in patients with cancer treated with bevacizumab: a meta-analysis of randomized controlled trials
- (2011) Xiao Feng Hang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Venous Thromboembolic Events With Chemotherapy Plus Bevacizumab: A Pooled Analysis of Patients in Randomized Phase II and III Studies
- (2011) Herbert I. Hurwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Brief Report: A Phase II Study of Sunitinib in Malignant Pleural Mesothelioma. The NCIC Clinical Trials Group
- (2011) Scott A. Laurie et al. Journal of Thoracic Oncology
- Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509
- (2011) Linda L. Garland et al. Journal of Thoracic Oncology
- Vatalanib in malignant mesothelioma: A phase II trial by the Cancer and Leukemia Group B (CALGB 30107)
- (2011) Thierry Jahan et al. LUNG CANCER
- Integrating Bevacizumab Into the Treatment of Patients With Early-Stage Breast Cancer: Focus on Cardiac Safety
- (2010) Denise A. Yardley Clinical Breast Cancer
- Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma
- (2010) Vanesa Gregorc et al. JOURNAL OF CLINICAL ONCOLOGY
- Bevacizumab Increases Risk for Severe Proteinuria in Cancer Patients
- (2010) S. Wu et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- A Phase II Study of Sorafenib in Malignant Mesothelioma: Results of Cancer and Leukemia Group B 30307
- (2010) Sarita Dubey et al. Journal of Thoracic Oncology
- Clinical Significance of Serum Vascular Endothelial Growth Factor in Malignant Pleural Mesothelioma
- (2010) Akihiro Yasumitsu et al. Journal of Thoracic Oncology
- Increased Risk of Serious Hemorrhage with Bevacizumab in Cancer Patients: A Meta-Analysis
- (2010) Sanjaykumar Hapani et al. ONCOLOGY
- Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma
- (2010) Noriko Hirayama et al. RESPIRATORY MEDICINE
- Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
- (2009) A. Scherpereel et al. EUROPEAN RESPIRATORY JOURNAL
- Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005
- (2009) N. Le Stang et al. INTERNATIONAL JOURNAL OF CANCER
- Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma
- (2008) David M. Jackman et al. CANCER
- Phase II study of pemetrexed in combination with carboplatin in patients with malignant pleural mesothelioma (MPM)
- (2007) B. Castagneto et al. ANNALS OF ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now